amplobiotechnology.com | Home

Robots.txt Information

Robot	Path	Permission
GoogleBot	/	✔
BingBot	/	✔
BaiduSpider	/	✔
YandexBot	/	✔
User-agent: * Allow: / # Optimization for Google Ads Bot User-agent: AdsBot-Google-Mobile User-agent: AdsBot-Google Disallow: /_api/* Disallow: /_partials* Disallow: /pro-gallery-webapp/v1/galleries/* # Block PetalBot User-agent: PetalBot Disallow: / Sitemap: https://www.amplobiotechnology.com/sitemap.xml # Auto generated, go to SEO Tools > Robots.txt Editor to change

Meta Tags

Title	Home \| Amplo
Description	OVERVIEW Amplo Biotechnology is a gene therapy company focused on the neuromuscular
Keywords	Discover, Advanced

Server Information

WebSite	amplobiotechnology.com
Host IP	23.236.62.147
Location	United States

Related Websites

                        Site
                        Rank
                    

More to Explore

amplobiotechnology.com Valuation

US$1,325,135

Last updated: 2023-05-09 18:32:03

amplobiotechnology.com has Semrush global rank of 7,987,341. amplobiotechnology.com has an estimated worth of US$ 1,325,135, based on its estimated Ads revenue. amplobiotechnology.com receives approximately 152,901 unique visitors each day. Its web server is located in United States, with IP address 23.236.62.147. According to SiteAdvisor, amplobiotechnology.com is safe to visit.

Traffic & Worth Estimates

Purchase/Sale Value	US$1,325,135
Daily Ads Revenue	US$1,224
Monthly Ads Revenue	US$36,697
Yearly Ads Revenue	US$440,353
Daily Unique Visitors	10,194
Note: All traffic and earnings values are estimates.

DNS Records

Host	Type	TTL	Data
amplobiotechnology.com.	A	3600	IP: 23.236.62.147
amplobiotechnology.com.	NS	3600	NS Record: ns3.netregistry.net.
amplobiotechnology.com.	NS	3600	NS Record: ns2.netregistry.net.
amplobiotechnology.com.	NS	3600	NS Record: ns1.netregistry.net.
amplobiotechnology.com.	MX	3600	MX Record: 0 amplobiotechnology-com.mail.protection.outlook.com.
amplobiotechnology.com.	TXT	3600	TXT Record: v=spf1 include:spf.protection.outlook.com -all
amplobiotechnology.com.	TXT	300	TXT Record: MS=ms90051505

HtmlToTextCheckTime:2023-05-09 18:32:03

top of page Home Overview Technology News Contact MEDIA & PRESS UPDATES AMPLO ANNOUNCES FINANCING ROUND October, 2021 THE MYASTHENIA ALLIANCE AUSTRALIA highlights AMPLO’S Work October, 2019 AMPLO LICENSES AAV-DOK7 FOR CONGENITAL MYASTENIA FROM UNIVERSITY OF TOKYO September, 2019 Home: About Us Home: Contact Home: News OVERVIEW Diseases of the neuromuscular junction have profound health effects including paralysis, breathing and swallowing difficulties. Amplo Biotechnology plans to develop multiple, potentially curative, Adeno-Associated Viral (AAV) therapies for the neuromuscular junction with an initial focus on congenital myasthenic syndromes. Amplo’s lead program, AMP-101 (AAV-Dok7), was developed by Professor Yuji Yamanashi’s group of the Institute of Medical Science at the University of Tokyo, and is applicable to multiple rare, severe diseases. Amplo is led by experienced AAV entrepreneurs: Al Hawkins is a gene therapy entrepreneur and investor. He was co-founder and Chairman

HTTP Headers

HTTP/1.1 301 Moved Permanently
Date: Mon, 01 Nov 2021 08:19:07 GMT
Content-Length: 0
Connection: keep-alive
location: https://www.amplobiotechnology.com/
strict-transport-security: max-age=120
Age: 23655
Server-Timing: cache;desc=hit, varnish;desc=hit, dc;desc=42
X-Seen-By: jeslxIFvDH4ulYwNNi+3Muwfbs+7qUVAqsIx00yI78k=,sHU62EDOGnH2FBkJkG/Wx8EeXWsWdHrhlvbxtlynkVh0NuQFvpZQ48Kl9xfz/tt3,m0j2EEknGIVUW/liY8BLLpKOvBhYRuLEqdCLHFrW+6dGkFvVdT2Nq6f3Hedj7ewB,2d58ifebGbosy5xc+FRalsN9WNSBxLhp5frWQpbO6js/Zb5FdtRm3H4saC7tu/cxSROjWPqNalLIehTnu9JLvQ==,2UNV7KOq4oGjA5+PKsX47HOECBdr6Pn2Dhzdc3z1NshYgeUJqUXtid+86vZww+nL
Cache-Control: no-cache
X-Wix-Request-Id: 1635754747.513984545852406831
X-Content-Type-Options: nosniff

HTTP/2 200 
date: Mon, 01 Nov 2021 08:19:07 GMT
content-type: text/html; charset=UTF-8
content-length: 292898
link: ; rel=preconnect; crossorigin;,; rel=preconnect;,; rel=preconnect; crossorigin;,; rel=preconnect; crossorigin;,; rel=preconnect;,; rel=preconnect; crossorigin;,
etag: W/"f65571ce688bae643f2f30e8077db34c"
content-language: en-US
strict-transport-security: max-age=120
age: 299374
set-cookie: ssr-caching=cache#desc=hit#varnish=hit#dc#desc=42; Max-Age=20; Expires=Thu, 28 Oct 2021 21:09:53 GMT
server-timing: cache;desc=hit, varnish;desc=hit, dc;desc=42
x-seen-by: wmgbEcS9zOENaefw7bU4YZZkpjMMVpZ6+DErTqZ6Qqo=,gv/XVF9HsGpk8A2KWukUzOwfbs+7qUVAqsIx00yI78k=,sHU62EDOGnH2FBkJkG/Wx8EeXWsWdHrhlvbxtlynkVisPSpdvxhEEQZ13gnr6W/r,m0j2EEknGIVUW/liY8BLLvn/1fMuxpYw/Htpcq27vLUa0sM5c8dDUFHeNaFq0qDu,2d58ifebGbosy5xc+FRalj+IWh0CTHGLMp6Js97T0DXxH4lBFdreLamoqBGmFIVRnqo3+r6ZJR2bT+x22pRStA==,2UNV7KOq4oGjA5+PKsX47HOECBdr6Pn2Dhzdc3z1NshYgeUJqUXtid+86vZww+nL
cache-control: no-cache
vary: Accept-Encoding
accept-ranges: bytes
x-wix-request-id: 1635754747.893988147901826984
x-content-type-options: nosniff
set-cookie: TS01e85bed=01f0e93131ad56591a989c0909a774364dd0c3b55b85d590428aeb6d503ad0c40a272e6489cfdb99e7f1df6cd0e370d4e0d841bd5b; Path=/;SameSite=none;Secure
server: Pepyaka/1.15.10

amplobiotechnology.com Whois Information

Domain Name: AMPLOBIOTECHNOLOGY.COM
Registry Domain ID: 2362291933_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.netregistry.net
Registrar URL: http://www.netregistry.com.au
Updated Date: 2021-01-28T08:58:47Z
Creation Date: 2019-02-19T21:39:42Z
Registry Expiry Date: 2022-02-19T21:39:42Z
Registrar: NetRegistry Pty Ltd.
Registrar IANA ID: 677
Registrar Abuse Contact Email: feedback@netregistry.com.au
Registrar Abuse Contact Phone: +61.299340501
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Name Server: NS1.NETREGISTRY.NET
Name Server: NS2.NETREGISTRY.NET
Name Server: NS3.NETREGISTRY.NET
DNSSEC: unsigned
>>> Last update of whois database: 2021-09-19T17:23:55Z <<<

amplobiotechnology.com valuation and analysis